Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Biosyent Inc V.RX

Alternate Symbol(s):  BIOYF

BioSyent Inc. is a specialty pharmaceutical company. The Company, through its wholly owned subsidiaries, BioSyent Pharma Inc., and BioSyent Pharma International Inc., acquires or licenses and develops pharmaceutical and other healthcare products for sale in Canada and certain international markets. Hedley Technologies Ltd., a wholly owned subsidiary operates the Company’s business marketing biologically and health friendly non-chemical insecticides. Its products include Combogesic, Cathejell, FeraMAX Pd Therapeutic 150, FeraMAX Pd Maintenance 45, FeraMAX Pd Powder 15, Gelclair, Inofolic, Proktis-M, RepaGyn, and Tibella. Combogesic is for the short-term management of mild to moderate acute pain and the reduction of fever in adults. Cathejell combines sterile gel and 2% lidocaine jelly in a collapsible syringe that is ready to use. FeraMAX Pd Therapeutic 150 is an oral hematinic that helps the body form red blood cells and is indicated for the treatment of iron deficiency anemia.


TSXV:RX - Post by User

Bullboard Posts
Comment by vicarioon May 19, 2016 4:49pm
243 Views
Post# 24890121

RE:RE:RE:Sales breakdown

RE:RE:RE:Sales breakdownThey are focussed on diversifying the revenue streams however it's been tricky as Feremax sales are still growing at 20%+/year.  They are also now selling the powder internationally which they are saying is a different revenue stream than Feremax but it's the same compound so not so sure I would classify it differently.  Either way they are doing a great job at taking the legacy product (pesticide) and Feremax profits and re-investing into other products.  Will take time; in the meantime they are growing at 25%/year with a very nice ROE.  As they build their cash position, we'll need to also have some clarity as to its deployment becuase it it sits as cash for too long this will serve to reduce their ROE and they won't really be maximizing the use of their assets.  A worry for another day though...
Bullboard Posts